協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/18 | 3,445 | 3,450 | 3,380 | 3,395 | -120 | -3.4% | 1,110,300 |
| 2021/11/17 | 3,605 | 3,610 | 3,485 | 3,515 | -115 | -3.2% | 921,300 |
| 2021/11/16 | 3,665 | 3,690 | 3,565 | 3,630 | -75 | -2% | 788,500 |
| 2021/11/15 | 3,675 | 3,720 | 3,665 | 3,705 | +35 | +1% | 485,300 |
| 2021/11/12 | 3,690 | 3,725 | 3,655 | 3,670 | -5 | -0.1% | 694,300 |
| 2021/11/11 | 3,680 | 3,725 | 3,660 | 3,675 | +5 | +0.1% | 504,000 |
| 2021/11/10 | 3,635 | 3,705 | 3,635 | 3,670 | -30 | -0.8% | 542,800 |
| 2021/11/09 | 3,760 | 3,785 | 3,695 | 3,700 | -90 | -2.4% | 677,400 |
| 2021/11/08 | 3,780 | 3,825 | 3,760 | 3,790 | +50 | +1.3% | 622,000 |
| 2021/11/05 | 3,700 | 3,750 | 3,665 | 3,740 | +40 | +1.1% | 697,400 |
| 2021/11/04 | 3,785 | 3,785 | 3,625 | 3,700 | +120 | +3.4% | 1,116,400 |
| 2021/11/02 | 3,615 | 3,620 | 3,455 | 3,580 | -245 | -6.4% | 2,521,100 |
| 2021/11/01 | 3,795 | 3,835 | 3,760 | 3,825 | +85 | +2.3% | 758,700 |
| 2021/10/29 | 3,730 | 3,740 | 3,670 | 3,740 | +5 | +0.1% | 584,700 |
| 2021/10/28 | 3,745 | 3,770 | 3,710 | 3,735 | -40 | -1.1% | 616,400 |
| 2021/10/27 | 3,730 | 3,780 | 3,720 | 3,775 | +40 | +1.1% | 443,200 |
| 2021/10/26 | 3,700 | 3,750 | 3,690 | 3,735 | +80 | +2.2% | 713,000 |
| 2021/10/25 | 3,660 | 3,690 | 3,635 | 3,655 | -35 | -0.9% | 538,100 |
| 2021/10/22 | 3,660 | 3,695 | 3,650 | 3,690 | +15 | +0.4% | 658,300 |
| 2021/10/21 | 3,750 | 3,750 | 3,655 | 3,675 | -100 | -2.6% | 805,400 |
| 2021/10/20 | 3,830 | 3,830 | 3,740 | 3,775 | +85 | +2.3% | 1,060,900 |
| 2021/10/19 | 3,715 | 3,750 | 3,665 | 3,690 | +25 | +0.7% | 558,800 |
| 2021/10/18 | 3,725 | 3,725 | 3,645 | 3,665 | -80 | -2.1% | 631,300 |
| 2021/10/15 | 3,670 | 3,755 | 3,670 | 3,745 | +80 | +2.2% | 784,000 |
| 2021/10/14 | 3,690 | 3,705 | 3,625 | 3,665 | -25 | -0.7% | 652,700 |
| 2021/10/13 | 3,685 | 3,735 | 3,670 | 3,690 | +5 | +0.1% | 596,800 |
| 2021/10/12 | 3,695 | 3,705 | 3,660 | 3,685 | -20 | -0.5% | 577,500 |
| 2021/10/11 | 3,650 | 3,735 | 3,635 | 3,705 | +5 | +0.1% | 754,800 |
| 2021/10/08 | 3,695 | 3,755 | 3,680 | 3,700 | +15 | +0.4% | 1,020,900 |
| 2021/10/07 | 3,700 | 3,750 | 3,680 | 3,685 | +25 | +0.7% | 920,100 |
| 2021/10/06 | 3,755 | 3,775 | 3,610 | 3,660 | -115 | -3% | 1,533,500 |
| 2021/10/05 | 3,835 | 3,875 | 3,740 | 3,775 | -155 | -3.9% | 1,109,000 |
| 2021/10/04 | 4,020 | 4,075 | 3,920 | 3,930 | -70 | -1.8% | 988,000 |
| 2021/10/01 | 4,080 | 4,080 | 3,970 | 4,000 | -25 | -0.6% | 962,600 |
| 2021/09/30 | 4,065 | 4,105 | 3,980 | 4,025 | -5 | -0.1% | 1,710,200 |
| 2021/09/29 | 4,035 | 4,090 | 4,000 | 4,030 | -75 | -1.8% | 1,044,400 |
| 2021/09/28 | 4,120 | 4,145 | 4,075 | 4,105 | -80 | -1.9% | 954,100 |
| 2021/09/27 | 4,205 | 4,240 | 4,185 | 4,185 | -25 | -0.6% | 669,500 |
| 2021/09/24 | 4,155 | 4,235 | 4,145 | 4,210 | +105 | +2.6% | 833,600 |
| 2021/09/22 | 4,110 | 4,145 | 4,060 | 4,105 | -25 | -0.6% | 691,500 |
| 2021/09/21 | 4,120 | 4,165 | 4,075 | 4,130 | +30 | +0.7% | 893,800 |
| 2021/09/17 | 4,075 | 4,120 | 4,040 | 4,100 | +20 | +0.5% | 1,078,000 |
| 2021/09/16 | 4,070 | 4,085 | 4,025 | 4,080 | ±0 | ±0% | 645,800 |
| 2021/09/15 | 4,085 | 4,090 | 4,045 | 4,080 | -10 | -0.2% | 587,900 |
| 2021/09/14 | 4,090 | 4,165 | 4,060 | 4,090 | +35 | +0.9% | 855,300 |
| 2021/09/13 | 4,035 | 4,065 | 3,985 | 4,055 | +20 | +0.5% | 650,100 |
| 2021/09/10 | 3,995 | 4,040 | 3,975 | 4,035 | +20 | +0.5% | 1,088,500 |
| 2021/09/09 | 4,040 | 4,070 | 3,980 | 4,015 | -60 | -1.5% | 791,400 |
| 2021/09/08 | 3,985 | 4,075 | 3,985 | 4,075 | +50 | +1.2% | 1,271,300 |
| 2021/09/07 | 4,000 | 4,080 | 3,980 | 4,025 | +60 | +1.5% | 1,304,800 |
851～
900
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
